Steroid-toxicity Insights Roundup
When we last connected, we had just launched our latest initiative to change prescriber behavior - Sam (Steroids and Me) - designed to provide steroid-treated patients with accessible, educational content about steroid side effects. Sam empowers patients to engage in shared decision-making with their providers, ultimately leading to better treatment outcomes and experiences.
Since then, our research team has uncovered a fascinating series of studies into steroid use in IBD patients, as well as a landmark paper investigating the staggering prevalence of steroid-induced myopathy in autoimmune blistering disease (AIBD) patients.
These exciting research discussions will continue in September with our next webinar, Quantifying steroid-toxicity in real-world data, where we will highlight the use of the GTI-MD in health economics outcomes research (HEOR) studies. Don’t forget to register before you head off for a summer vacation.
In conversation with... Noreen Henig, MD
Noreen Henig, MD, has built a distinguished career as a physician, scientist and executive in the healthcare industry. She recently held the role of Chief Medical Officer at Kezar Life Sciences, where she focused on developing treatments for autoimmune diseases and oncology. She currently serves on the board of directors at Avidity Biosciences.
Unveiling the Prevalence of Steroid-induced Myopathy
A landmark study has highlighted that the risks of developing steroid-induced myopathy are higher than previously recognized.
Recommended by LinkedIn
Increasing Steroid Usage Linked to Escalating Burden of Side Effects for IBD Patients
A poster presentation at the 2024 ECCO Congress has highlighted the magnitude and impact of steroid overuse on IBD patients.
Experience the STOX® Digital Platform
Your free trial of the GTI-MD is waiting for you. Experience it now >
Steritas is working toward a world free of steroid dependency, enabling the measurement and monitoring of steroid-toxicity to optimize the treatment of inflammatory diseases and improve the quality of patient care around the world.
Learn more at steritas.com.
Sincerely,
CEO, Steritas